Protease and reverse transcriptase genetic polymorphism in HIV type 1 subtype A variants predominating in CIS countries

Molekulyarnaya Biologiya

Volumn 39, Issue 6, 2005, Pages 1063-1071

  Sukhanova, A L ^a   Rondinskii, N I ^b   Bogoslovskayar, E V ^c   Kruglova, A I ^c   Bashkirova, L Yu ^c   Tsyganova, G M ^c   Shipulin, G A ^c   Kazennova, E V ^a   Alikina, Yu I ^a   Zverev, S Ya ^d   Grishechkin, A E ^a   Pokrovsky, V V ^c   Bobkova, M R ^c   Bobkov, A F ^a  

^a D I IVANOVSKY INSTITUTE OF VIROLOGY   (Russian Federation)

^b MOSCOW INSTITUTE OF PHYSICS AND TECHNOLOGY   (Russian Federation)

^c Central Research Institute of Epidemiology   (Russian Federation)

^d Russia Regional AIDS Center   (Russian Federation)

Author keywords

Antiretroviral therapy; Drug resistance mutations; HIV 1; Polymorphism; Protease; Reverse transcriptase; Subtype A

Indexed keywords

PROTEINASE; RNA DIRECTED DNA POLYMERASE;

AMINO ACID SUBSTITUTION; ANTIBIOTIC RESISTANCE; ARTICLE; GENETIC POLYMORPHISM; GENETICS; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; POINT MUTATION; USSR; VIRUS GENOME;

AMINO ACID SUBSTITUTION; COMMONWEALTH OF INDEPENDENT STATES; DRUG RESISTANCE, VIRAL; GENOME, VIRAL; HIV INFECTIONS; HIV PROTEASE; HIV-1; HIV-1 REVERSE TRANSCRIPTASE; POINT MUTATION; POLYMORPHISM, GENETIC;

EID: 33644819415     PISSN: 00268984     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Ammaranond P., Cunningham P., Oelrichs R., Suzuki K., Harris C., Leas L., Grulich A., Cooper D.A., Kelleher A.D. 2003. Rates of transmission of antiretroviral drug resistant strains of HIV-1. J. Clin. Virol. 26, 153-161.
2. Taylor S., Cane P., Hue S., Xu L., Wrin T., Lie Y., Hellmann N., Petropoulos C., Workman J., Ratcliffe D., Choudhury B., Pillay D. 2003. Identification of a transmission chain of HIV type I containing drug resistance-associated mutations. AIDS Res. Hum. Retrovir. 19, 353-361.
3. Quinones-Mateu M.E., Arts E.J. 2001. HIV-1 Fitness: Implications for Drug Resistance, Disease Progression, and Global Epidemic Evolution. In: HIV Sequence Compendium 2001. Eds Kuiken C, Foley B., Hahn B., Marx P., McCutchan F., Mellors J.W., Wolinsky S., Korber B. Los Alamos: Theoretical Biology and Biophysics Group, Los Alamos National Laboratory, LA-UR 02-2877.
4. Kantor R., Katzenstein D. 2003. Polymorphism in HIV-1 non-subtype B protease and reverse transcriptase and its potential impact on drug succeptibility and drug resistance evolution. AIDS Rev. 5, 25-35.
5. Bobkov A.F., Kazennova E.V., Selimova L.M., Khanina T.A., Ryabov G.S., Bobkova M.R., Sukhanova A.L., Kravchenko A.V., Ladnaya N.N., Weber J.N., Pokrovsky V.V. 2004. Temporal trends in the HIV-1 epidemic in Russia: predominance of subtype A. J. Med. Virol. 74, 191-196.
6. Roudinskii N.I., Sukhanova A.L., Kazennova E.V., Weber J.N., Pokrovsky V.V., Mikhailovich V.M., Bobkov A.F. 2004. Diversity of human immunodeficiency virus type 1 subtype A and CRF03-AB protease in Eastern Europe: selection of the V77I variant and its rapid spread in injecting drug user populations. J. Virol. 78, 11276-11287.
7. Delwart E.L., Shpaer E.G., Louwagie J., McCutchan F., Grez M., Ruebsamen-Waigmann H., Mullins J.I. 1993. Genetic relationships determined by a DNA heteroduplex mobility assay. Science. 262, 1257-1261.
8. Heyndrickx L., Janssens W., Zekeng L., Musonda R., Anagonou S., van der Auwera G., Coppens S., Vereecken K., De Witte K., Van Rampelbergh R., Kahindo M., Morison L., McCutchan F.E., Carr J.K., Albert J., Essex M., Goudsmit J., Asjo B., Salminen M., Buve A., van der Groen G. 2000. Simplified strategy for detection of recombinant human immunodeficiency virus type 1 group M isolates by gag/env heteroduplex mobility assay. J. Virol. 74, 363-370.
9. Boom R., Saliman C.J.A., Heijting R., Wertheim-van Dillen P.M., van der Noordaa J. 1990. Rapid and simple method for purification of nucleic acids. J. Clin. Microbiol. 28, 495-503.
10. Bobkov A.F., Kazennova E.V., Khanina T.A., Bobkova M.R., Selimova L.M., Kravchenko A.V., Pokrovsky V.V., Weber J.N. 2001. An HIV type I subtype A strain of low genetic diversity continues to spread among injecting drug users in Russia: study of the new local outbreaks in Moscow and Irkutsk. AIDS Res. Hum. Retroviruses. 17, 257-261.
11. Servais J., Lambert C., Fontaine E., Plesseria J.-M., Robert I., Arendt V., Staub T., Schneider F., Hemmer B., Burtonboy G., Schmit J.-C. 2001. Variant human immunodeficiency virus type 1 proteases and response to combination therapy including a protease inhibitor. Antimicrob. Agents Chemother. 45, 893-900.
12. Weber J., Rangel H.R., Chakraborty B., Marotta M.L., Valdez H., Fransen K., Florence E., Connick E., Smith K.Y., Colebunders R.L., Landay A., Kuritzkes D.R., Lederman M.M., Vanham G., Quinones-Mateu M.E. 2003. Role of baseline pol genotype in HIV-1 fitness evolution. J. Aquir. Immune Defic. Syndr. 33, 448-460.
13. Iversen A.K., Shafer R.W., Wehrly K., Winters M.A., Mullins J.I., Chesebro B., Merigan T.C. 1996. Multidrug-resistant human immunodeficiency virus type 1 strains resulting from combination antiretroviral therapy. J. Virol. 70, 1086-1090.
14. Shirasaka T., Kavlick M.F., Ueno T., Gao W.Y., Kojima E., Alcaide M.L., Chokekijchai S., Roy B.M., Arnold E., Yarchoan R., Mitsuya H. 1995. Emergence of human immunodeficiency virus type 1 variants with resistance to multiple dideoxynucleosides in patients receiving therapy with dideoxynucleosides. Proc. Natl. Acad. Sci. USA. 92, 2398-2402.
15. Kosalaraksa P., Kavlick M.F., Maroun V., Le R., Mitsuya H. 1999. Comparative fitness of multi-dideoxynucleoside-resistant human immunodeficiency virus type 1 (HIV-1) in an in vitro competitive HIV-1 replication assay. J. Virol. 73, 5356-5363.